#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigoid Pouchitis Gaucher's disease type III Extranodal marginal zone B-cell lymphoma (MALT type) Eosinophilic granulomatosis with polyangiitis Osteogenesis imperfecta Rhabdomyosarcoma Alternating hemiplegia of childhood Peritoneal neoplasm B-cell lymphoma Familial dilated cardiomyopathy Small intestine neuroendocrine tumour Small intestine adenocarcinoma Soft tissue sarcoma Mastocytosis More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Basic Information Mucopolysaccharidosis – Trials in Disease Wolfram syndrome – Trials in Disease Pituitary-dependent Cushing’s syndrome – Treatment Breast angiosarcoma – Treatment Myxofibrosarcoma – Basic Information Tuberous sclerosis complex – Diagnostics Hereditary motor and sensory neuropathy – Diagnostics Burkitt’s lymphoma – Treatment Mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vaborbactam Secukinumab Tigulixostat Ziltivekimab Magnesium Oxide, Light [89Zr]Bms-986279 Iberdomide Molidustat Sodium Aluminium Hydroxide ALLERGEN EXTRACTS Domperidone Methotrexate Disodium Ramucirumab Cilastatin Sodium Sulfamethoxazole ALPROSTADIL Tofacitinib Citrate Lasofoxifene Neratinib Poa Pratensis More therapies…

    Learn about Your Condition

    Hydrocele Anal cancer Tricuspid valve disease Venous thrombosis limb Peripheral artery thrombosis Primary hyperthyroidism Nodular melanoma Oesophageal carcinoma Papulopustular rosacea Lip and/or oral cavity cancer Skin papilloma Tetanus Biliary adenoma Epithelioid sarcoma Diabetic autonomic neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study on Tranexamic Acid to Reduce Early Relapse in Melanoma Patients Undergoing Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Tranexamic Acid
    • Placebo
    Denmark

  • Study on Elacestrant and Triptorelin for Premenopausal Women with Early Luminal Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Elacestrant Dihydrochloride
    • Triptorelin Acetate
    • Tamoxifen Citrate
    Spain

  • Study of drug combination (capecitabine, fluorouracil, oxaliplatin, calcium folinate) to prevent cancer recurrence in patients with detectable ctDNA after rectal cancer surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    The Netherlands

  • Study on Salbutamol and Ipratropium Bromide for Treating Moderate Asthma Attacks in Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Ipratropium Bromide Monohydrate
    Spain

  • Study on Durvalumab and Tremelimumab for Liver Cancer Patients Undergoing Electroporation Ablation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    • Tremelimumab
    France

  • Study on the Effectiveness of CL-AD-MSC-002 Injections for Dry Mouth in Patients with Sjögren’s Syndrome

    Recruiting

    1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Cl-Ad-Msc-002
    Denmark
Previous Page
1 … 10 11 12 13 14 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!